Benedict C Creagh-Brown
Overview
Explore the profile of Benedict C Creagh-Brown including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
79
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chhetri I, Hunt J, Mendis J, Forni L, Kirk-Bayley J, White I, et al.
J Clin Med
. 2022 Jul;
11(14).
PMID: 35887701
Muscle wasting is implicated in the pathogenesis of intensive care unit acquired weakness (ICU-AW), affecting 40% of patients and causing long-term physical disability. A repetitive vascular occlusion stimulus (RVOS) limits...
2.
Chhetri I, Hunt J, Mendis J, Patterson S, Puthucheary Z, Montgomery H, et al.
Trials
. 2019 Jul;
20(1):456.
PMID: 31340849
Background: Forty per cent of critically ill patients are affected by intensive care unit-acquired weakness (ICU-AW), to which skeletal muscle wasting makes a substantial contribution. This can impair outcomes in...
3.
Nikolakopoulou Z, Hector L, Creagh-Brown B, Evans T, Quinlan G, Burke-Gaffney A
Biomark Med
. 2019 Feb;
13(3):205-218.
PMID: 30810341
Aim: We investigated whether plasma levels of the inflammation marker S100A8/A9, could predict acute kidney injury (AKI) onset in patients undergoing cardiac surgery necessitating cardiopulmonary bypass (CPB). Patients & Methods:...
4.
Konstantara E, Vandrevala T, Cox A, Creagh-Brown B, Ogden J
Health Psychol Open
. 2017 Jan;
3(1):2055102915622928.
PMID: 28070383
This study investigated how intensivists make decisions regarding withholding and withdrawing treatment for patients at the end of their lives. This involved completing in-depth interviews from two sites of the...
5.
6.
Creagh-Brown B, Quinlan G, Hector L, Evans T, Burke-Gaffney A
Mediators Inflamm
. 2013 Oct;
2013:496031.
PMID: 24089588
Background: The receptor for advanced glycation end products (RAGE) is an inflammation-perpetuating receptor, and soluble RAGE (sRAGE) is a marker of cellular RAGE expression. This study investigated whether raised plasma...
7.
Creagh-Brown B, Burke-Gaffney A, Evans T
Crit Care Med
. 2011 Feb;
39(3):589-90.
PMID: 21330859
No abstract available.
8.
Creagh-Brown B, Quinlan G, Evans T, Burke-Gaffney A
Intensive Care Med
. 2010 Jul;
36(10):1644-1656.
PMID: 20631986
Background: The sepsis syndromes, frequently complicated by pulmonary and cardiac dysfunction, remain a major cause of death amongst the critically ill. Targeted therapies aimed at ameliorating the systemic inflammation that...
9.
Creagh-Brown B, Quinlan G, Evans T
Crit Care Med
. 2010 May;
38(6):1487-90.
PMID: 20502141
No abstract available.
10.
Creagh-Brown B, Griffiths M, Evans T
Crit Care
. 2009 Jun;
13(3):221.
PMID: 19519946
Nitric oxide (NO) is an endogenous mediator of vascular tone and host defence. Inhaled nitric oxide (iNO) results in preferential pulmonary vasodilatation and lowers pulmonary vascular resistance. The route of...